NOCLAUD

PACKAGING

• Noclaud
• Tablets: Cilostazol 50mg
• Box: 4 blisters x 14 tablets, flat round tablets, bevelled edges, 6mm diameter, white or almost white. One side has a stylized letter E, the other side has code 601
• Active ingredient: Cilostazol 50mg
• Manufacturer: Egis Pharmaceuticals Private Limited Company
• Country: Hungary

INDICATIONS

• Cilostazol is indicated to improve maximum and pain-free walking distance in patients with intermittent claudication without rest pain and without peripheral tissue necrosis (Fontaine peripheral arterial disease stage II).
• Cilostazol is a second-line treatment for patients who have not improved their symptoms after lifestyle changes (including smoking cessation and moderate exercise) and other appropriate interventions.

CONTRAINDICATIONS

• Hypersensitivity to cilostazol or any of the ingredients
• Severe renal impairment: rapid creatinine clearance 25 ml/min
• Severe or moderate hepatic impairment
• Congestive heart failure
• Pregnant women
• Patients with a tendency to bleed easily (such as progressive gastric ulcer, recent cerebral hemorrhage (within 6 months), diabetic retinopathy, poorly controlled hypertension.
• Patients with a history of tachycardia, ventricular fibrillation, multiple ventricular extrasystoles with or without appropriate treatment, patients with QTc interval.
• Patients with a history of severe tachycardia.
• Patients who are taking 2 or more anticoagulants or antiplatelet agents concurrently.
• Patients with unstable angina, myocardial infarction or coronary intervention within the last 6 months.

​